INDIANAPOLIS — A laboratory headquartered in Indianapolis agreed to pay the state $9.6 million after being accused of double-dipping in government payments for COVID-19 testing.
The United States Department of Justice alleges that Patients Choice Laboratories (PCL) violated the False Claims Act and the Anti-Kickback Statute for alleged false billing to Medicare. PCL agreed to resolve the allegations by paying out a $9,620,000 settlement to the state of Indiana, but admitted to no wrongdoing.
The government alleges that from December 2020 until May 2022, PCL knowingly submitted claims to Medicare for respiratory pathogen panels (RPPs) that were either medically unnecessary or obtained through kickbacks…